Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.
Instituto de Biomedicina, Caracas, Venezuela.
J
J
Convit
D000818:Animals; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007891:Leishmania / Q000276:immunology*; D016773:Leishmaniasis, Cutaneous / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D016774:Leishmaniasis, Diffuse Cutaneous / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D007897:Leishmaniasis, Mucocutaneous / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D016052:Protozoan Vaccines / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D014687:Venezuela
D016207:Cytokines; D016052:Protozoan Vaccines